Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies

Authors

Marina Magrey (ORCID: https://orcid.org/0000-0002-6520-5619)
Martín Rudwaleit (ORCID: https://orcid.org/0000-0001-5445-548X)
Jonathan Kay (ORCID: https://orcid.org/0000-0002-8970-4260)
Karl Gaffney (ORCID: https://orcid.org/0000-0002-7863-9176)
Maureen Dubreuil (ORCID: https://orcid.org/0000-0002-6253-1515)
Atul Deodhar (ORCID: https://orcid.org/0000-0002-2130-1246)
T. Vaux
Helena Marzo‐Ortega (ORCID: https://orcid.org/0000-0002-9683-3407)
Ute Massow
V. Taieb (ORCID: https://orcid.org/0000-0003-0655-8630)
Victoria Navarro‐Compán (ORCID: https://orcid.org/0000-0002-4527-852X)
Christine de la Loge (ORCID: https://orcid.org/0000-0002-5896-5927)
Philip J. Mease (ORCID: https://orcid.org/0000-0002-6620-0457)
Maria Antonietta D’Agostino (ORCID: https://orcid.org/0000-0002-5347-0060)

Institutions

Università Cattolica del Sacro Cuore (IT)
Boston University (US)
University of Leeds (GB)
Oregon Health & Science University (US)
University Hospitals of Cleveland (US)
Leeds Teaching Hospitals NHS Trust (GB)
Norfolk and Norwich University Hospital (GB)
Agostino Gemelli University Polyclinic (IT)
Swedish Medical Center (US)
UCB Pharma (France) (FR)
NIHR Leeds Musculoskeletal Biomedical Research Unit (GB)
Klinikum Bielefeld (DE)
UMass Memorial Medical Center (US)
UCB Pharma (Germany) (DE)
Case Western Reserve University (US)
UCB Pharma (Belgium) (BE)

Publication Details

Journal: RMD Open
Published: 2025-10-01
DOI: https://doi.org/10.1136/rmdopen-2025-006013
Citations: 1
Primary Topic: Spondyloarthritis Studies and Treatments
Type: article
Field-Weighted Citation Impact: 1.67

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies

Marina Magrey, Martín Rudwaleit, Jonathan Kay, Karl Gaffney et al.

Oct 1, 2025

1 citations

RMD Open

Spondyloarthritis Studies and Treatments

1.67

article

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies

Marina Magrey, Martín Rudwaleit, Jonathan Kay, Karl Gaffney, Maureen Dubreuil, Atul Deodhar, T. Vaux, Helena Marzo‐Ortega, Ute Massow, V. Taieb, Victoria Navarro‐Compán, Christine de la Loge, Philip J. Mease, Maria Antonietta D’Agostino

October 1, 2025article en

1 citations

Abstract

No abstract available for this paper.

RMD OpenVol. 11(4)

Università Cattolica del Sacro Cuore (IT), Boston University (US), University of Leeds (GB), Oregon Health & Science University (US), University Hospitals of Cleveland (US), Leeds Teaching Hospitals NHS Trust (GB), Norfolk and Norwich University Hospital (GB), Agostino Gemelli University Polyclinic (IT), Swedish Medical Center (US), UCB Pharma (France) (FR), NIHR Leeds Musculoskeletal Biomedical Research Unit (GB), Klinikum Bielefeld (DE), UMass Memorial Medical Center (US), UCB Pharma (Germany) (DE), Case Western Reserve University (US), UCB Pharma (Belgium) (BE)

Openalex Percentile: Top 11%

Spondyloarthritis Studies and Treatments

1.67

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.